Keyphrases
Melanoma
77%
Sentinel Lymph Node
36%
Metastasis
27%
Melanoma Patients
24%
Danish Cancer Registry
18%
Early Melanoma
18%
Skin Melanoma
18%
Mediastinal Lymph Node Metastasis
18%
Validation Studies
18%
Primary mucinous Carcinoma of the Skin
18%
Melanoma Risk
18%
Cancer Treatment
18%
Management Recommendations
18%
Clinical Presentation
18%
Distant Lymph Node Metastases
18%
Malignant Melanoma
18%
Pathology Report
18%
Spontaneous Hemothorax
18%
Merkel Cell Carcinoma
18%
European Organizations
18%
Adnexal
18%
Uveal Melanoma
18%
Choroidal Melanoma
18%
Downstaging
18%
Rare Cause
18%
Cutaneous Tumors
18%
Thin Melanoma
18%
Tumor
15%
Metastatic Disease
13%
Three-level Model
10%
Immunohistochemistry
10%
Cancer Registry
9%
Malignant Blue Nevus
9%
Blue Primary
9%
Local Tumor Resection
9%
Mucinous Adenocarcinoma
9%
Rare Malignant Tumor
9%
Sentinel Lymph Node Metastasis
9%
Sweat Gland
9%
Recurring
9%
Variable Presentations
9%
Cutaneous Adnexal Tumors
9%
Mammae
9%
Plaque Brachytherapy
9%
Multicenter Cohort Study
9%
Molecular Analysis
9%
Lung
9%
Histology
9%
Cutaneous Metastasis
9%
Regional Lymph Node Metastasis
9%
Medicine and Dentistry
Nodular Melanoma
100%
Metastatic Carcinoma
48%
Lymph Node Metastasis
24%
Sentinel Node
21%
Melanoma Sentinel Node
18%
Merkel Cell Carcinoma
18%
Cancer Registry
18%
Mucinous Carcinoma
18%
Cutaneous Adnexal Tumor
18%
Hemothorax
18%
Cancer Treatment
18%
Uveal Melanoma
18%
Choroid Melanoma
18%
Skin Biopsy
18%
Biopsy Technique
18%
Melanoma
18%
Skin Cancer
18%
Neoplasm
16%
Malignant Neoplasm
10%
Blue Nevus
9%
Lymph Node
9%
Adjuvant Radiotherapy
9%
Adnexal Tumor
9%
Cancer Surgery
9%
Clinical Finding
9%
Diagnosis
9%
Metastatic Uvea Melanoma
9%
Mediastinal Lymph Node
9%
Brachytherapy
9%
Physical Examination
9%
Disease Exacerbation
9%
Central Nervous System
9%
Health Care Cost
8%
Immunohistochemistry
7%
Skin Defect
6%
Sweat Gland
6%
Sentinel Lymph Node Metastasis
6%
Skin Metastasis
6%
Primary Tumor
6%
Sentinel Lymph Node
6%
Prognostic Factor
6%
Colon
6%
